Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while he continues to serve as the company’s Chief Financial Officer. Ayari will hold these dual responsibilities for a six-month period or until a permanent Managing Director is appointed, whichever occurs first.
This decision was sanctioned by Sanofi India’s Board of Directors following the recommendation from the Nomination and Remuneration Committee, as disclosed in the company’s filing with the Bombay Stock Exchange (BSE). With a career spanning over 24 years, Ayari brings extensive global experience, having spent eight years with Sanofi and 16 years at Pfizer.
His professional journey covers leadership roles across diverse regions including North Africa, Russia, Central Asia, and India. Ayari’s expertise encompasses financial strategy, regulatory compliance, and fostering cross-functional teamwork, making him well-equipped to steer the company through this transitional phase.
His dual role reflects Sanofi India’s strategic approach to leadership continuity and financial stewardship. As Interim Managing Director, Ayari is expected to guide the organization’s ongoing operations while maintaining the company’s financial health and compliance standards.
With his deep understanding of both finance and business operations, Ayari’s appointment “reflects the company’s commitment to maintaining strong leadership and operational stability,” ensuring that Sanofi India remains well-positioned in a competitive pharmaceutical market during this period.
The company is actively seeking a permanent Managing Director to take over the leadership role. Until then, Rachid Ayari’s stewardship aims to provide a steady hand in navigating the company’s strategic and operational priorities.
